NCT07112378View on ClinicalTrials.gov

A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis

PHASE3RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 13, 2026

Primary Completion Date

August 21, 2028

Study Completion Date

December 11, 2028

Conditions
Eosinophilic Esophagitis (EoE)
Interventions
DRUG

dupilumab

Administered as defined in the protocol

Trial Locations (1)

30342

RECRUITING

GI Care for Kids LLC, Atlanta

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY